Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 29
Filter
2.
Actas dermo-sifiliogr. (Ed. impr.) ; 108(6): e45-e48, jul.-ago. 2017. ilus
Article in Spanish | IBECS | ID: ibc-164514

ABSTRACT

La terapia fotodinámica tiene una importante acción antimicrobiana. Se presentan 2 casos clínicos de úlceras crónicas en las extremidades inferiores sobreinfectadas por hongos y bacterias de difícil manejo, en los que el tratamiento fotodinámico con azul de metileno como fotosensibilizante resultó en la curación clínica y microbiológica. No se presentaron efectos adversos reseñables. La posibilidad de utilizar la terapia fotodinámica con azul de metileno en el manejo de las úlceras crónicas sobreinfectadas constituye una interesante alternativa para reducir el uso de antibióticos y disminuir la aparición de resistencias (AU)


Photodynamic therapy (PDT) is a therapeutic modality with significant antimicrobial activity. We present 2 cases of chronic lower limb ulcers in which fungal and bacterial superinfection complicated management. PDT with methylene blue as the photosensitizer led to clinical and microbiological cure with no significant adverse effects. PDT with methylene blue is a valid option for the management of superinfected chronic ulcers, reducing the use of antibiotics and the induction of resistance (AU)


Subject(s)
Humans , Female , Adult , Aged , Methylene Blue/therapeutic use , Phototherapy , Skin Ulcer/therapy , Wound Infection/therapy , Pseudomonas Infections/therapy , Dermatomycoses/therapy , Leg Ulcer/therapy , Anti-Bacterial Agents/therapeutic use , Antifungal Agents/therapeutic use , Pseudomonas aeruginosa/isolation & purification , Fusarium/isolation & purification
3.
Actas Dermosifiliogr ; 108(6): e45-e48, 2017.
Article in English, Spanish | MEDLINE | ID: mdl-28411862

ABSTRACT

Photodynamic therapy (PDT) is a therapeutic modality with significant antimicrobial activity. We present 2 cases of chronic lower limb ulcers in which fungal and bacterial superinfection complicated management. PDT with methylene blue as the photosensitizer led to clinical and microbiological cure with no significant adverse effects. PDT with methylene blue is a valid option for the management of superinfected chronic ulcers, reducing the use of antibiotics and the induction of resistance.


Subject(s)
Fusariosis/drug therapy , Fusarium/drug effects , Leg Ulcer/microbiology , Methylene Blue/therapeutic use , Mycoses/drug therapy , Photochemotherapy , Photosensitizing Agents/therapeutic use , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Superinfection/drug therapy , Adult , Aged , Burns, Electric/complications , Burns, Electric/microbiology , Chronic Disease , Female , Fusariosis/etiology , Humans , Immunocompromised Host , Intraoperative Complications , Leg Ulcer/complications , Mycoses/etiology , Pseudomonas Infections/etiology , Superinfection/etiology , Wound Healing , Wound Infection/drug therapy , Wound Infection/microbiology
4.
Rev. clín. esp. (Ed. impr.) ; 217(1): 15-20, ene.-feb. 2017. tab, graf
Article in Spanish | IBECS | ID: ibc-159525

ABSTRACT

Objetivo. Describir las características de las bacteriemias, según la edad, en un hospital comunitario. Material y método. Estudio prospectivo de las bacteriemias en el año 2011. Los pacientes se clasificaron en 3 grupos de edad: menos de 65, de 65 a 79 y 80 o más años. Se recogieron variables de los pacientes y de los episodios. Resultados. Se analizaron 233 bacteriemias en 227 pacientes (23,8% en<65; 38,3% entre 65 y 79; y 37,9% en≥80 años). La enfermedad de base más frecuente en todos los grupos fue la diabetes mellitus. En los pacientes muy ancianos el índice de Charlson fue mayor, hubo una menor proporción de factores exógenos y casi un 25% eran dependientes graves (índice de Barthel<20). Escherichia coli fue el germen más frecuente y el foco principal fue el urológico. En los pacientes≥80 años predominó el origen de la infección asociado a cuidados sanitarios, la expresividad clínica menos grave (sepsis) (66,3%) y la mortalidad más elevada (29,1%), respecto a los de menor edad. Conclusiones. Los pacientes muy ancianos con bacteriemia presentaron menos factores exógenos, más comorbilidad y una situación funcional peor; el foco más frecuente fue el urológico y el origen el asociado a cuidados sanitarios. A pesar de que su presentación clínica fue menos grave, su mortalidad fue superior, siendo el grado de dependencia una variable de riesgo independiente muy relevante (AU)


Objective. To describe the characteristics of bacteraemias, according to age, in a community hospital. Material and method. A prospective study of bacteraemias was conducted in 2011. The patients were classified into 3 age groups: younger than 65 years, 65 to 79, and 80 or older. The study collected variables on the patients and episodes. Results. The study analysed 233 bacteraemias in 227 patients (23.8% in those younger than 65 years; 38.3% in the 65 to 79 age group; and 37.9% in the 80 years or older group). The most common underlying disease in all the groups was diabetes mellitus. In the most elderly patients, the Charlson index was highest, there was a lower proportion of exogenous factors, and almost 25% were severely dependent (Barthel index<20). Escherichia coli was the most common germ, and the main focus was urological. The patients aged 80 years or older had predominantly healthcare-associated infections, less severe symptoms (sepsis) (66.3%) and higher mortality (29.1%) compared with the younger patients. Conclusions. The very elderly patients with bacteraemia presented fewer exogenous factors, greater comorbidity and a poorer functional situation. The most common focus was urological and the origin was healthcare related. Despite their less severe clinical presentation, these patients’ mortality was greater, and their degree of dependence was a highly relevant independent risk factor (AU)


Subject(s)
Humans , Male , Female , Middle Aged , Aged , Aged, 80 and over , Bacteremia/classification , Bacteremia/diagnosis , Hospitals, Community/standards , Hospitals, Community , Risk Factors , Tracheostomy/methods , Parenteral Nutrition/methods , Repertory, Barthel , Prospective Studies , Comorbidity , Multivariate Analysis
5.
J Eur Acad Dermatol Venereol ; 31(2): 347-354, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27515478

ABSTRACT

BACKGROUND: Onychomycosis is a common fungal nail infection that responds poorly to antifungals. OBJECTIVE: To investigate the efficacy and safety of methyl aminolevulinate (MAL) photodynamic therapy (PDT) in the treatment of onychomycosis. METHODS: A multicentre (3), randomized, placebo-controlled clinical trial compared the effects of three sessions of urea (40%) plus conventional MAL-PDT with urea (40%) plus placebo (red light) photodynamic therapy (pPDT) in onychomycosis patients. Efficacy, both clinical (onychomycosis severity index, OSI) and microbiological, was blindly evaluated after 36 weeks of follow-up. RESULTS: Forty patients were analysed in the trial. Twenty-two received MAL-PDT and 18 pPDT. A complete response (OSI = 0) was observed for four patients (18.18%) in the MAL-PDT group and one (5.56%) in the pPDT group (NTT 7.92, 95% CI: 2.98-9.69, P = 0.23). A decrease in OSI score of over 75% (OSI75) was achieved by 40.91% of the patients in the MAL-PDT group and 16.67% in the pPDT group (P = 0.096). Microbiological cure was achieved by seven patients (31.82%) in the MAL-PDT group and two (11.11%) in the pPDT group (P = 0.178). MAL-PDT resulted in better rates of clinical response [OSI >75%: 53.85% vs. 18.75% (P =0.048)] and microbiological cure [41.56% vs. 7.14% (P = 0.037)] in non-dystrophic vs. dystrophic onychomycosis patients. No significant side-effects were reported. The limitations of the study were the reduced sample size and the unexpected efficacy of the control treatment, which was attributed to the 40% urea pre-treatment. CONCLUSION: This study did not show significant differences between urea 40% + MAL-PDT and urea 40% + pPDT in the treatment of onychomycosis. However, some results suggest that this treatment may constitute an alternative for dermatophyte and non-dermatophyte mould onychomycosis in patients not eligible for systemic treatment, particularly in the absence of total nail dystrophy.


Subject(s)
Aminolevulinic Acid/analogs & derivatives , Onychomycosis/drug therapy , Photochemotherapy , Photosensitizing Agents/therapeutic use , Aged , Aminolevulinic Acid/therapeutic use , Female , Humans , Male , Middle Aged , Placebos
6.
Rev Clin Esp (Barc) ; 217(1): 15-20, 2017.
Article in English, Spanish | MEDLINE | ID: mdl-27773222

ABSTRACT

OBJECTIVE: To describe the characteristics of bacteraemias, according to age, in a community hospital. MATERIAL AND METHOD: A prospective study of bacteraemias was conducted in 2011. The patients were classified into 3 age groups: younger than 65 years, 65 to 79, and 80 or older. The study collected variables on the patients and episodes. RESULTS: The study analysed 233 bacteraemias in 227 patients (23.8% in those younger than 65 years; 38.3% in the 65 to 79 age group; and 37.9% in the 80 years or older group). The most common underlying disease in all the groups was diabetes mellitus. In the most elderly patients, the Charlson index was highest, there was a lower proportion of exogenous factors, and almost 25% were severely dependent (Barthel index<20). Escherichia coli was the most common germ, and the main focus was urological. The patients aged 80 years or older had predominantly healthcare-associated infections, less severe symptoms (sepsis) (66.3%) and higher mortality (29.1%) compared with the younger patients. CONCLUSIONS: The very elderly patients with bacteraemia presented fewer exogenous factors, greater comorbidity and a poorer functional situation. The most common focus was urological and the origin was healthcare related. Despite their less severe clinical presentation, these patients' mortality was greater, and their degree of dependence was a highly relevant independent risk factor.

9.
Actas dermo-sifiliogr. (Ed. impr.) ; 106(10): 795-805, dic. 2015. ilus, tab
Article in Spanish | IBECS | ID: ibc-146615

ABSTRACT

La onicomicosis, o infección fúngica de las uñas, constituye una de las enfermedades micóticas más prevalentes en la población. Su tratamiento tiene una efectividad limitada, además de ser largo y tedioso y, en el caso de los antifúngicos sistémicos, no está exento de efectos adversos. La terapia fotodinámica (TFD) podría ser una buena alternativa para las infecciones cutáneas superficiales, entre ellas la onicomicosis. El presente artículo revisa la experiencia publicada, tanto in vitro como in vivo, acerca de la utilidad de la TFD en las onicomicosis, mostrando el potencial de diversos fotosensibilizantes, así como sus limitaciones. Desde el punto de vista clínico el azul de metileno y el ácido 5-aminolevulínico muestran tasas de curación del 80% y el 43% respectivamente al año de seguimiento. Finalmente, basado en la bibliografía y en la propia experiencia, se propone un protocolo de 3 sesiones de TFD, usando metil-aminolevulinato 16% como fotosensibilizante y luz roja (lambda = 630 nm, 37J.cm−2), separadas por 1 o 2 semanas. Estas irán precedidas de la aplicación de urea 40% durante unos días. Nuevos ensayos clínicos deben optimizar los protocolos y establecer qué pacientes se benefician especialmente de recibir este tratamiento


Onychomycosis, or fungal infection of the nails, is one of the most prevalent fungal diseases in the general population. Treatment is of limited effectiveness, tedious, and must be administered for long periods. Furthermore, systemic antifungal agents are associated with adverse effects. Photodynamic therapy (PDT) may prove to be a viable alternative in the treatment of superficial skin infections, including onychomycosis. We review articles relating to the usefulness of PDT in onychomycosis in both in vitro and in vivo settings and discuss the potential and limitations of various photosensitizing agents. In vivo, methylene blue and 5-aminolevulinic acid have led to cure rates in 80% and 43% of cases, respectively, at 12 months. Finally, based on data in the literature and our own experience, we propose a protocol of 3 PDT sessions, separated by an interval of 1 or 2 weeks, using methyl aminolevulinate 16% as a photosensitizing agent and red light (Lambda = 630 nm, 37J.cm -2). Each session is preceded by the topical application of urea 40% over several days. Clinical trials are needed to optimize PDT protocols and to identify those patients who will benefit most from this treatment


Subject(s)
Female , Humans , Male , Onychomycosis/therapy , Phototherapy/instrumentation , Phototherapy , Aminolevulinic Acid/therapeutic use , 5-Aminolevulinate Synthetase/therapeutic use , Methylene Blue/therapeutic use , Photosensitizing Agents/therapeutic use , Onychomycosis/drug therapy , Onychomycosis/physiopathology , Fungi/radiation effects
10.
Actas Dermosifiliogr ; 106(10): 795-805, 2015 Dec.
Article in English, Spanish | MEDLINE | ID: mdl-26427737

ABSTRACT

Onychomycosis, or fungal infection of the nails, is one of the most prevalent fungal diseases in the general population. Treatment is of limited effectiveness, tedious, and must be administered for long periods. Furthermore, systemic antifungal agents are associated with adverse effects. Photodynamic therapy (PDT) may prove to be a viable alternative in the treatment of superficial skin infections, including onychomycosis. We review articles relating to the usefulness of PDT in onychomycosis in both in vitro and in vivo settings and discuss the potential and limitations of various photosensitizing agents. In vivo, methylene blue and 5-aminolevulinic acid have led to cure rates in 80% and 43% of cases, respectively, at 12 months. Finally, based on data in the literature and our own experience, we propose a protocol of 3 PDT sessions, separated by an interval of 1 or 2 weeks, using methyl aminolevulinate 16% as a photosensitizing agent and red light (λ=630 nm, 37 J.cm(-2)). Each session is preceded by the topical application of urea 40% over several days. Clinical trials are needed to optimize PDT protocols and to identify those patients who will benefit most from this treatment.


Subject(s)
Onychomycosis/drug therapy , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Aminolevulinic Acid/administration & dosage , Aminolevulinic Acid/analogs & derivatives , Aminolevulinic Acid/therapeutic use , Antifungal Agents/therapeutic use , Clinical Protocols , Clinical Trials as Topic , Drug Administration Schedule , Evidence-Based Medicine , Fungi/drug effects , Fungi/radiation effects , Humans , Methylene Blue/administration & dosage , Methylene Blue/therapeutic use , Photosensitizing Agents/administration & dosage , Treatment Outcome , Urea/administration & dosage , Urea/therapeutic use
13.
Mycoses ; 57(1): 35-42, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23905682

ABSTRACT

Antimicrobial photodynamic therapy (aPDT) is an emerging alternative to treat infections based on the use of photosensitisers (PSs) and visible light. To investigate the fungicidal effect of PDT against azole-resistant Candida albicans strains using two PSs with a different mechanism of action, hypericin (HYP) and 1,9-dimethyl methylene blue (DMMB), comparing their efficacy and the reactive oxygen species (ROS) species involved in their cytotoxicity. Azole-resistant and the azole-susceptible C. albicans strains were used. Solutions of 0.5 and 4 McFarland inoculum of each Candida strain were treated with different concentrations of each PS, and exposed to two light-emitting diode light fluences (18 and 37 J cm⁻²). Mechanistic insight was gained using several ROS quenchers. The minimal fungicidal concentration of HYP for ≥3 log10 CFU reduction (0.5 McFarland) was 0.62 µmol l⁻¹ for most strains, whereas for DMMB it ranged between 1.25 and 2.5 µmol l⁻¹. Increasing the fluence to 37 J cm⁻² allowed to reduce the DMMB concentration. Higher concentrations of both PSs were required to reach a 6 log10 reduction (4 McFarland). H2O2 was the main phototoxic species involved in the fungicidal effect of HYP-aPDT whereas ¹O2 was more important for DMMB-based treatments. aPDT with either HYP or DMMB is effective in killing of C. albicans strains independent of their azole resistance pattern. HYP was more efficient at low fungal concentration and DMMB at higher concentrations.


Subject(s)
Antifungal Agents/pharmacology , Azoles/pharmacology , Candida albicans/drug effects , Candida albicans/radiation effects , Drug Resistance, Fungal , Methylene Blue/analogs & derivatives , Perylene/analogs & derivatives , Photosensitizing Agents/pharmacology , Anthracenes , Candida albicans/growth & development , Candidiasis/drug therapy , Candidiasis/microbiology , Combined Modality Therapy , Humans , Light , Methylene Blue/pharmacology , Microbial Sensitivity Tests , Perylene/pharmacology , Photochemotherapy
16.
Infection ; 41(3): 701-3, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23242963

ABSTRACT

We describe a case of meningitis due to Streptococcus suis with the unusual ST3 genotype. The bacterial pathogen was isolated from blood samples. S. suis genotype ST3 was initially isolated from carrier pigs, but it has not been previously associated with invasive human infections. The patient developed serious endogenous bilateral endophthalmitis which resulted in severe visual deficiency.


Subject(s)
Meningitis, Bacterial/diagnosis , Streptococcal Infections/diagnosis , Streptococcus suis/classification , Streptococcus suis/genetics , Adult , Blindness/diagnosis , Blindness/etiology , Blindness/microbiology , Blindness/pathology , Blood/microbiology , Endophthalmitis/complications , Endophthalmitis/diagnosis , Endophthalmitis/microbiology , Endophthalmitis/pathology , Genotype , Humans , Male , Meningitis, Bacterial/complications , Meningitis, Bacterial/microbiology , Meningitis, Bacterial/pathology , Molecular Typing , Streptococcal Infections/complications , Streptococcal Infections/microbiology , Streptococcal Infections/pathology , Streptococcus suis/isolation & purification
17.
Eur J Clin Microbiol Infect Dis ; 31(3): 257-60, 2012 Mar.
Article in English | MEDLINE | ID: mdl-21626450

ABSTRACT

Thirteen vancomycin-resistant and teicoplanin-susceptible Enterococcus faecalis isolates were recovered from unrelated patients in three Spanish hospitals from November 2009 to December 2010. All isolates carried the vanB2 gene, showed indistinguishable or closely-related PFGE patterns and were ascribed to the sequence type ST6 (included into the high-risk clonal-complex CC2). They showed a multiresistance phenotype (erythromycin, tetracycline, ciprofloxacin and high-level-resistance to streptomycin, gentamicin and kanamycin) and harboured the aac(6')-aph(2"), ant(6)-Ia, and tet(M)+/-tet(L) genes. All isolates produced gelatinase and harboured the gelE gene, but not the esp or hyl genes. The inclusion of the vanB2 gene into the Tn5382 transposon was demonstrated in one isolate. Clonal dissemination of vanB2-containing the E. faecalis strain is demonstrated.


Subject(s)
Bacterial Proteins/genetics , Drug Resistance, Multiple, Bacterial/genetics , Enterococcus faecalis/genetics , Vancomycin Resistance/genetics , Aged , Aged, 80 and over , Enterococcus faecalis/isolation & purification , Female , Gelatinases/metabolism , Gram-Positive Bacterial Infections/epidemiology , Gram-Positive Bacterial Infections/genetics , Gram-Positive Bacterial Infections/microbiology , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Spain/epidemiology , Urinary Tract Infections/microbiology
18.
Clin Microbiol Infect ; 17(6): 923-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21682806

ABSTRACT

Skin infection associated with methicillin-resistant Staphylococcus aureus (MRSA)-ST398 was detected in a pig-farmer, and MRSA-ST398 isolates were also detected in nasal samples of the patient and of 11/12 pigs on his farm. Twelve MRSA isolates were obtained from skin lesions (n = 6) and nasal samples (n = 6) of the patient in two sampling moments and 11 MRSA isolates from nasal samples of pigs. They were typed as t011-SCCmecIVa-agrI and t108-SCCmecV-agrI (patient and pigs) and t588-SCCmecV-agrI (patient). The following resistance genes were detected (number isolates): tet(K) (1), tet(L) (23), tet(M) (13), erm(A) (13), erm(C) (13), msr(A) (11), lnu(A) (21), aph(2'')-acc(6') (3), ant(4') (13), aph(3') (12), dfrS1 (15) and dfrK (22). Seventeen human and animal MRSA-ST398 isolates showed indistinguishable PFGE patterns (A1-spa-t011 or B2-spa-t108) and similar phenotypic-genotypic characteristics, including the presence of the lnu(A) gene, associated with lincomycin resistance. Potential pig-to-human transference of ST398 is suggested in this study. The first detection of the lnu(A) gene in MRSA-ST398 is reported.


Subject(s)
Methicillin-Resistant Staphylococcus aureus/classification , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Skin Infections/diagnosis , Staphylococcal Skin Infections/microbiology , Swine/microbiology , Zoonoses/microbiology , Zoonoses/transmission , Agriculture , Animals , Bacterial Typing Techniques , Carrier State/microbiology , Carrier State/veterinary , Cluster Analysis , Electrophoresis, Gel, Pulsed-Field , Genes, Bacterial , Genotype , Humans , Male , Methicillin-Resistant Staphylococcus aureus/genetics , Middle Aged , Molecular Epidemiology , Molecular Typing , Nasal Mucosa/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL